Search research articles
Contact Us
Filters
Showing results (101-110 of 265) with videos related to
Page
of 27
Sort By:
Pharmacogenomics
|
October 4, 2011
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen
Ann M Moyer, Vera J Suman, Richard M Weinshilboum, et al.
The Oncologist
|
September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score
Arif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.
NPJ Breast Cancer
|
January 25, 2019
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
Stephen Johnston, Miguel Martin, Angelo Di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
Matthew P Goetz, David Toft, Joel Reid, et al.
Journal of the American Medical Informatics Association : JAMIA
|
December 6, 2011
Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record
Guergana K Savova, Janet E Olson, Sean P Murphy, et al.
Breast Cancer Research and Treatment
|
January 21, 2018
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)
Jame Abraham, Humberto Caldera, Robert Coleman, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Breast Cancer Research and Treatment
|
July 4, 2021
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy
Mei-Yin C Polley, Maura N Dickler, Jason Sinnwell, et al.
Nucleic Acids Research
|
October 24, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Plos One
|
February 6, 2013
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens
John R Hawse, Malayannan Subramaniam, Muzaffer Cicek, et al.
Page
of 27
Search research articles
Search
Showing results (101-110 of 265) with videos related to
Sort By:
Page
of 27
Pharmacogenomics
|
October 4, 2011
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen
Ann M Moyer, Vera J Suman, Richard M Weinshilboum, et al.
The Oncologist
|
September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score
Arif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.
NPJ Breast Cancer
|
January 25, 2019
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer
Stephen Johnston, Miguel Martin, Angelo Di Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
Matthew P Goetz, David Toft, Joel Reid, et al.
Journal of the American Medical Informatics Association : JAMIA
|
December 6, 2011
Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record
Guergana K Savova, Janet E Olson, Sean P Murphy, et al.
Breast Cancer Research and Treatment
|
January 21, 2018
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)
Jame Abraham, Humberto Caldera, Robert Coleman, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Breast Cancer Research and Treatment
|
July 4, 2021
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy
Mei-Yin C Polley, Maura N Dickler, Jason Sinnwell, et al.
Nucleic Acids Research
|
October 24, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networks
Xiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.
Plos One
|
February 6, 2013
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens
John R Hawse, Malayannan Subramaniam, Muzaffer Cicek, et al.
Page
of 27